- Research Grants
I am currently working as a postdoc at the Faculty of Pharmaceutical Sciences of Ribeirão Preto - University of São Paulo, developing research in the area of hematology, immunology and oncology, aiming to understand alterations of the hematopoietic niche in the development of hematological malignancies. PhD in Biosciences Applied to Pharmacy by the Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP (2014 to 2018) with emphasis in Hematology and working with Myeloproliferative Neoplasias and its association with the alterations in the signaling pathways and the inflammatory process. (BEPE-FAPESP) developed at the Gustave Roussy-Villejuif-France Institute, under the guidance of Dr. William Vainchenker, in which the studied the myeloproliferative neoplasms in animal models with CALR del52 mutation and their role in hematopoiesis. Master's Degree in Sciences by the Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP (2012 to 2014), where I carried out the work in Immunology, focusing on the search for immunological biomarkers of HIV + monocytes. Bachelor in Biomedicine with qualification in Clinical Pathology by Centro Universitário de Araraquara (2007 to 2010). (Source: Lattes Curriculum)
Myeloproliferative neoplasms (MPN) are hematological disorders characterized by increased cell proliferation and accumulation of mature and precursor myeloid cells in peripheral blood independently of cytokine stimuli and growth factors.The discovery of genetic mutations since 2005 has contributed to the elucidation of the physiopathology of MPN. However, despite the knowledge accumulat...
Chronic myeloproliferative neoplasms (CMPN) are haematological disease characterized by the increase of mature hematopoietic cells of one or more of the myeloid series (granulocyte, erythrocyte , megakaryocyte or mast cells) proliferation. Among the CMPN we will investigate the polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (MF).CMPN may present the JAK...
Myeloproliferative neoplasms (MPN) are haematological disorders characterized by increased proliferation and accumulation of mature myeloid cells of one or more of the myeloid series (granulocytic, erythroid or megakaryocytic). Among the MPN are polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). Patients with these disorders may present the JAK2V617F...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|